GENE THERAPY:SAVIO L. C. WOO

From: Congressional Testimony | Date: May 24, 2000 | Copyright information

00-00-0000
TESTIMONY IN SENATOR FRIST'S SUBCOMMITTEE HEARING ON GENE THERAPY

I am Savio L. C. Woo, Professor and Director at the Institute for Gene Therapy and Molecular Medicine at the Mount Sinai School of Medicine in New York, and I am currently serving as president of the American Society of Gene Therapy (ASGT). I am happy to testify on behalf of the Society, which is a non-profit, voluntary and professional organization. It was founded in 1996 with about 1000 members, and has grown to over 2000 members at present. The Society's mission is to promote research and education in ...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and trade journal articles from HighBeam Research

(Including press releases, facts, information, and biographies)

Gene Therapy `Oversold' By Researchers, Journalists; NIH Advisers Cite Nearly Uniform Failure
; Gene therapy as a treatment for...everyone involved in gene therapy. Researchers were...disease gene" to trying gene therapy, without first using...promoting mediocre gene therapy projects just for...accused of exaggerating gene therapy's "promise" to ...
Primer on Medical Genomics Part X: Gene therapy
; Gene therapy is defined as any...preclinical and clinical gene therapy research have been...the past 15 years; gene therapy is now a highly...clinical test of gene therapy in 1989, more than 600 gene therapy protocols have been...patients have received ...
Therapeutic delivery issues in gene therapy, part 1: Vectors
; ...meaningful gene transfer into mammalian...for in vivo gene therapy. Ease of...feasibility of safe gene transfer (4). The first human gene therapy trial was...involved ex vivo gene transfer of the adenosine...targeted for gene therapy include ...
Gene therapy: Are you a believer?
; ...investment in gene therapy companies holds...technology of gene transfer holds great promise...including efficient gene transfer into cells, antigenicity...vectors used for gene transfer, cell and tissue...integration. Gene therapy is all about...companies ...
Guest editorial: the promise of gene therapy.(Opinion)
; ...3,102 members. Gene therapy societies in other...Health funding for gene therapy research grew 8...million. About 80% of gene therapy trials occur in...early stages of gene therapy research: 66% of...Early research in gene therapy focused on ...
American Society of Gene Therapy to Hold Annual Meeting in Denver May 31-June 4
; ...American Society of Gene Therapy will be holding...the preeminent gene therapy research and...attendance of 2,500 gene therapy scientists and...vehicles for gene transfer and expression...vehicles for gene transfer. In conjunction...studies in the ...
Latecomer Boston labs eyeing gene therapy
; ...science of gene therapy is rapidly...the second gene therapy patient, afflicted...nearly 70 gene therapy experiments...here follow gene transfer experiments...results of the gene transfer treatments...assembling a gene therapy program ...
NEW INITIATIVES TO PROTECT PARTICIPANTS IN GENE THERAPY TRIALS
; ...protection in gene therapy trials, the...studies for gene therapy. These two...initiatives -- the Gene Therapy Clinical Trial...Plan and the Gene Transfer Safety Symposia...several recent gene therapy trials has...conduct of gene therapy ...
Progress in gene therapy: Seeing is believing
; ...basic concept of gene therapy is simple and...overcome before gene therapy could be added...of effective gene therapy are the limited...importance. For gene transfer, viral vectors...vehicles for gene transfer, are...the concept of gene ...
Gene therapy: human germline genetic modifications--assessing the scientific, socioethical, and religious issues.
; ...that facilitate gene transfer, which is the...technology of gene therapy. (1) The timeliness...The success of gene therapy depends largely...been 95 approved gene transfer trials worldwide...the utility of gene therapy for the treatment...more trials of ...